PRMT5 and atherosclerosis: As IFN‐gamma is highly expressed in atherosclerotic lesions and has emerged as a significant factor in atherogenesis,20 we hypothesized that PRMT5 inhibition would result in an augmented immune response and increased atherosclerosis development in our atherosclerotic mouse model.